It has been reported by Gilbert S. et al., that GH, through inhibition of NF-κB activation [71], decreases gut inflammation and improves or maintains gut barrier function, which ultimately inhibit development of IBD as shown in intestinal epithelial cell-specific STAT5 knockout mice [123]. The gene discussed is GH1; the disease is inflammatory bowel disease.